Preserving Time in Reproductive Medicine
Few areas of medicine are as closely connected to time as fertility.
Reproductive potential changes with age, but it can also be affected unexpectedly by illness, surgery, medication, chemotherapy, radiotherapy, or changes in a person’s life circumstances. For many patients, the question is not whether they want to have a child, but whether they will still have that possibility when the time is right.
Fertility preservation emerged to address this question. By freezing eggs, sperm, or embryos for possible future use, reproductive medicine can preserve biological material at an earlier point in time.
At Jinemed, cryopreservation has developed as an extension of the institution’s work in IVF, embryology, male infertility, reproductive genetics, and long-term patient care. The purpose is not to promise a future pregnancy. It is to protect a possibility that might otherwise become smaller or disappear.
From Slow Freezing to Vitrification
Freezing living reproductive cells is scientifically demanding because cells contain water. During conventional slow freezing, ice crystals may form and damage delicate cellular structures.
The development of vitrification transformed cryopreservation. Vitrification is an ultra-rapid cooling technique that uses carefully controlled cryoprotective solutions and very fast temperature reduction to minimise the formation of damaging ice crystals. The cell enters a glass-like state and is stored at an extremely low temperature in liquid nitrogen.
This advance was especially important for egg freezing. Human eggs are large, water-rich cells and were historically more difficult to freeze successfully than embryos or sperm. As vitrification became established, egg cryopreservation developed into a recognised fertility-preservation option.
For an IVF laboratory, however, vitrification is not simply a device or a single technical step. Its reliability depends on laboratory experience, precise timing, validated protocols, accurate identification, safe storage, and careful warming when the patient returns to use the frozen material.
The process reflects one of Jinemed’s central principles: technology becomes valuable only when it is supported by trained people and a disciplined system.
Egg Freezing
Egg freezing allows mature, unfertilised eggs to be preserved for possible future use.
The process generally begins with an assessment of ovarian reserve through medical history, ultrasound examination, and hormone testing. If treatment is appropriate, the ovaries are stimulated with medication so that several follicles can develop during the same cycle. The eggs are then collected under sedation or anaesthesia, assessed by the embryology team, and mature eggs suitable for preservation are vitrified.
If the patient later decides to use the eggs, they are carefully warmed in the laboratory. Surviving mature eggs are generally fertilised using ICSI, after which embryo development is observed before a suitable embryo is considered for transfer.
Egg freezing preserves eggs at the biological age at which they were collected. It does not stop the patient herself from ageing, reverse a decline that has already occurred, or guarantee that every frozen egg will survive, fertilise, become an embryo, implant, or lead to a live birth.
Two factors are especially important when discussing future expectations:
- The patient’s age when the eggs are frozen
- The number of mature eggs preserved
For this reason, responsible counselling is essential. Patients should understand both the potential value of preservation and the limits of what can be predicted for an individual.
Medical Fertility Preservation
For some patients, fertility preservation is not primarily about postponing parenthood. It is part of preparing for medical treatment.
Chemotherapy, radiotherapy, ovarian surgery, testicular surgery, and certain medical conditions can affect reproductive cells or the organs that produce them. The degree of risk varies according to diagnosis, age, treatment type, medication, dose, and individual fertility status.
When possible, fertility should be discussed soon after diagnosis and before treatment that may damage reproductive function begins. The available time may be limited, and decisions often need to be coordinated rapidly among oncologists, surgeons, fertility specialists, embryologists, and the patient.
For women, ovarian stimulation and egg collection can often be organised within a short treatment window when the medical team considers it safe. Depending on the patient’s circumstances, eggs may be frozen unfertilised or embryos may be created and preserved.
For men, sperm freezing can often be arranged more quickly and, when medically possible, before chemotherapy, radiotherapy, or reproductive surgery.
These conversations can be emotionally difficult. A patient who has just received a serious diagnosis may suddenly be asked to think about future parenthood. Clear communication, psychological sensitivity, and cooperation between medical disciplines are therefore as important as the laboratory procedure itself.
Embryo Cryopreservation
Embryo freezing has long been an important part of IVF treatment.
During an IVF cycle, several eggs may be collected and fertilised. When more suitable embryos develop than are planned for immediate transfer, additional embryos may be vitrified for possible future use in accordance with the patient’s consent and applicable regulations.
Embryo cryopreservation can provide several clinical possibilities:
- A later frozen embryo transfer after an unsuccessful fresh transfer
- A future attempt without repeating ovarian stimulation and egg collection
- Postponing transfer when the endometrium or hormone environment is not appropriate
- A freeze-all strategy when there is a medical reason not to proceed with fresh transfer
- Preserving embryos while genetic testing is completed
- Attempting another pregnancy in the future using embryos created at an earlier age
Frozen embryo transfer is not a secondary or inferior form of treatment. In many situations, it is a deliberately planned part of the IVF pathway.
As with all fertility treatment, outcomes depend on multiple factors, including the patient’s age when the embryos were created, embryo development, genetic factors, uterine conditions, laboratory quality, and individual medical history.
Sperm Freezing
Sperm cryopreservation is one of the longest-established methods of fertility preservation.
It may be considered before medical treatments that could damage sperm production, before surgery involving the reproductive system, or when future sperm availability may be uncertain. It may also form part of an IVF plan when a sample needs to be secured before egg collection.
The laboratory evaluates and processes the sample before dividing it into carefully identified storage units. When needed, the sample is warmed and prepared for the appropriate treatment method, which may include insemination, conventional IVF, or ICSI depending on sperm quality and the clinical plan.
In cases where sperm cannot be obtained through ejaculation, a urologist may assess whether surgically retrieved sperm can be collected and frozen. These cases require close coordination between urology, embryology, and the reproductive medicine team.
Freezing sperm does not guarantee that every cell will survive warming or that treatment will result in pregnancy. However, it can preserve an important future option, sometimes within a very short period before urgent medical treatment begins.
The Cryostorage System
Fertility preservation does not end when a sample is frozen.
Eggs, sperm, and embryos may remain in storage for years. Throughout this time, the laboratory carries an ongoing responsibility for identification, documentation, tank monitoring, temperature control, maintenance, security, patient consent, and communication regarding storage requirements.
Every sample must remain traceable to the correct patient. Labelling, witnessing procedures, electronic and written records, storage maps, and access controls all form part of a reliable cryostorage system.
Patients also have responsibilities. Contact details should remain current, required consent documentation must be renewed when applicable, and decisions regarding continued storage must comply with national regulations and institutional procedures.
The frozen material may be microscopic, but the responsibility surrounding it is permanent and deeply personal.
Preserving Eggs, Sperm, or Embryos: Different Decisions
The three principal forms of fertility preservation are not interchangeable.
Egg freezing preserves unfertilised reproductive cells and leaves decisions about a future sperm source until later. Embryo freezing preserves eggs after fertilisation and may provide more information about early embryo development, but it also creates legal, ethical, and consent considerations involving both partners. Sperm freezing is generally less invasive and can often be completed rapidly, but its future use still depends on sperm survival, quality, and the reproductive circumstances of the patient or couple.
The appropriate option depends on medical urgency, age, ovarian reserve, relationship and consent considerations, diagnosis, treatment plan, available time, and applicable law.
For this reason, fertility preservation should be planned individually rather than presented as a standard package.
International Patients and Long-Term Planning
International patients considering fertility preservation face additional questions.
They may need to understand how many visits are required, where follow-up examinations can be completed, how long biological material may be stored, which documents and consents are necessary, and what regulations apply to future use or any proposed cross-border movement of reproductive cells or embryos.
These issues should be clarified before treatment begins. Rules governing assisted reproduction and the transport or use of reproductive material differ between countries and can change over time. A plan that is medically possible may still require regulatory review.
Through Jinemed and IVF Turkey, international treatment planning is coordinated with the understanding that fertility preservation is a long-term medical relationship—not a procedure completed on the day of freezing.
Honest Expectations
Fertility preservation is sometimes described as “stopping the biological clock.” The phrase is memorable, but it is medically incomplete.
Cryopreservation can preserve eggs, sperm, or embryos at a particular moment. It cannot guarantee how many will survive warming, whether fertilisation will occur, whether an embryo will develop normally, or whether a future transfer will result in pregnancy and live birth.
It also cannot protect against every future medical condition or age-related pregnancy risk.
Responsible fertility preservation therefore requires a balance between hope and realism. Patients should receive individual estimates based on age, test results, expected egg or sperm numbers, medical diagnosis, and available scientific evidence.
The goal is not to sell certainty. It is to preserve opportunity while ensuring that patients understand what that opportunity may realistically mean.
The Future of Fertility Preservation
Cryobiology continues to develop through improved vitrification methods, safer storage systems, fertility preservation protocols adapted to urgent medical treatment, and research involving ovarian and testicular tissue.
Future technologies may expand the possibilities available to patients who cannot currently undergo standard egg or sperm collection. Yet every development will need to be evaluated through scientific evidence, safety, ethics, and long-term outcomes.
For Jinemed, the future of fertility preservation remains connected to the values that have guided the institution throughout its history: multidisciplinary collaboration, laboratory precision, informed consent, ethical responsibility, and individualised patient care.
Protecting a Possibility
The true value of fertility preservation is not measured only by the number of samples placed into storage.
It is measured by the possibility they may represent years later: the possibility of attempting pregnancy after medical recovery, of using eggs collected at a younger age, of avoiding another ovarian stimulation cycle, or of preserving reproductive choice before an uncertain treatment.
Not every frozen egg, sperm cell, or embryo will ultimately be used. Not every attempt will result in a child. But for many patients, having a preserved option can carry profound medical and emotional value.
At Jinemed, that possibility is protected through science, careful laboratory practice, long-term responsibility, and honest communication.